+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurovascular Stents - Global Market Trajectory & Analytics

  • ID: 5140252
  • Report
  • April 2021
  • Region: Global
  • 171 Pages
  • Global Industry Analysts, Inc
Global Neurovascular Stents Market to Reach $2.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Neurovascular Stents estimated at US$919.6 Million in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 12.3% over the period 2020-2027. Carotid Artery Stents, one of the segments analyzed in the report, is projected to record 12.8% CAGR and reach US$1.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Intracranial Stents segment is readjusted to a revised 11.1% CAGR for the next 7-year period.



The U.S. Market is Estimated at $271.5 Million, While China is Forecast to Grow at 11.8% CAGR

The Neurovascular Stents market in the U.S. is estimated at US$271.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$361.7 Million by the year 2027 trailing a CAGR of 11.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 10.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.

Select Competitors (Total 42 Featured):
  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates
Frequently Asked Questions about the Global Market for Neurovascular Stents

What is the estimated value of the Global Market for Neurovascular Stents?

The Global Market for Neurovascular Stents was estimated to be valued at $919.6 Million in 2020.

What is the growth rate of the Global Market for Neurovascular Stents?

The growth rate of the Global Market for Neurovascular Stents is 12.5%, with an estimated value of $2100.0 Million by 2027.

What is the forecasted size of the Global Market for Neurovascular Stents?

The Global Market for Neurovascular Stents is estimated to be worth $2100.0 Million by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2025 and % CAGR
  • Table 2: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 3: World 16-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2009, 2020 & 2025
  • Table 4: World Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2025 and % CAGR
  • Table 5: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 6: World 16-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2009, 2020 & 2025
  • Table 7: World Current & Future Analysis for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2025 and % CAGR
  • Table 8: World Historic Review for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 9: World 16-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2009, 2020 & 2025
  • Table 10: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2025 and % CAGR
  • Table 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2009, 2020 & 2025
  • Table 13: World Current & Future Analysis for Ambulatory surgical centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2025 and % CAGR
  • Table 14: World Historic Review for Ambulatory surgical centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 15: World 16-Year Perspective for Ambulatory surgical centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2009, 2020 & 2025

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 16: USA Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 17: USA Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 18: USA 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 19: USA Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 20: USA Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 21: USA 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • CANADA
  • Table 22: Canada Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 23: Canada Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 24: Canada 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 25: Canada Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 26: Canada Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 27: Canada 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • JAPAN
  • Table 28: Japan Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 29: Japan Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 30: Japan 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 31: Japan Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 32: Japan Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 33: Japan 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • CHINA
  • Table 34: China Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 35: China Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 36: China 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 37: China Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 38: China Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 39: China 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • EUROPE
  • Table 40: Europe Current & Future Analysis for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2025 and % CAGR
  • Table 41: Europe Historic Review for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 42: Europe 16-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2009, 2020 & 2025
  • Table 43: Europe Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 44: Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 45: Europe 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 46: Europe Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 47: Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 48: Europe 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • FRANCE
  • Table 49: France Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 50: France Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 51: France 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 52: France Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 53: France Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 54: France 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • GERMANY
  • Table 55: Germany Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 56: Germany Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 57: Germany 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 58: Germany Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 59: Germany Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 60: Germany 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • ITALY
  • Table 61: Italy Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 62: Italy Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 63: Italy 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 64: Italy Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 65: Italy Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 66: Italy 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • UNITED KINGDOM
  • Table 67: UK Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 68: UK Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 69: UK 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 70: UK Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 71: UK Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 72: UK 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • REST OF EUROPE
  • Table 73: Rest of Europe Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 74: Rest of Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 75: Rest of Europe 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 76: Rest of Europe Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 77: Rest of Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 78: Rest of Europe 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • ASIA-PACIFIC
  • Table 79: Asia-Pacific Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 80: Asia-Pacific Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 81: Asia-Pacific 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 82: Asia-Pacific Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 83: Asia-Pacific Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 84: Asia-Pacific 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025
  • REST OF WORLD
  • Table 85: Rest of World Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 86: Rest of World Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 87: Rest of World 16-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2009, 2020 & 2025
  • Table 88: Rest of World Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2025 and % CAGR
  • Table 89: Rest of World Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory surgical centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2009 through 2019 and % CAGR
  • Table 90: Rest of World 16-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory surgical centers for the Years 2009, 2020 & 2025

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown